P21 (WAF1/Cip1/Sdi1/Pic1) mRNA is expressed in neuroblastoma cell lines but not in Ewing's sarcoma and primitive neuroectodermal tumor cell lines

Pediatrics International

Volumn 39, Issue 5, 1997, Pages 590-594

  Maeda, Taro ^a   Nishimura, Noriyuki ^b   Nakamura, Hajime ^b   Sano, Kimihiko ^b  

^a Konan Hospital Foundation Rokko Island Hospital   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ewing's sarcoma; Neuroblastoma; P21; P53; Primitive neuroectodermal tumor

Indexed keywords

GENE PRODUCT; PROTEIN P21;

AMINO ACID SUBSTITUTION; ARTICLE; CELL LINE; DNA FLANKING REGION; EWING SARCOMA; GENE MUTATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROECTODERM TUMOR; NORTHERN BLOTTING; POINT MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BLOTTING, NORTHERN; CELL LINE; HUMANS; NEUROBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; ONCOGENE PROTEIN P21(RAS); POINT MUTATION; RNA, MESSENGER; SARCOMA, EWING'S; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030869389     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03646.x     Document Type: Article

References (38)

1. El-Deiry WS, Tokino T., Victor E. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–25.
2. Harper JW, Adami GR, Wei N., Keyomorsi K., Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin dependent kinases. Cell 1993; 75; 805–16.
3. Noda A., Ning Y., Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res. 1994; 211: 90–8.
4. Hunter T. Braking the cycle. Cell 1993; 75: 839–41.
5. Xiong Y., Hannon GJ, Zhang H., Casso D., Kobayasi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701–4.
6. McBride OW, Merry D., Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Prot: Natl Acad. Sci. USA. 1986; 83: 130–4.
7. Martinez J., Georgoff I., Levine AJ Cellular localization and cell cycle regulation by temperature-sensitive p53 protein. Genes Dev. 1991; 5: 151–9.
8. Lin D., Shield MT, Ullrich SJ, Appella E., Mercer WE. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl Acad. Sci. USA. 1992; 89: 9210–14.
9. Hillstein M., Sidransky D., Vogelstein B., Harris CC. p53 mutation in human cancers. Science 1991; 253: 49–53.
10. Levine AJ, Momand J., Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453–6.
11. Nigro J., Preisinger AC, Jessup WK et al. Mutations in p53 gene occur in diverse human tumor types. Nature 1989; 342: 705–8.
12. Baker SJ, Fearon ER, Nigro JM et al. Chromosome 17 deletions and p53 mutations in colorectal carcinomas. Science 1989; 244: 217–21.
13. Yoshinori M., Kenshi H., Takao S. Detection of aberration of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res. 1991; 51: 3356–61.
14. Mackay J., Steel CM, Elder PA, Forrest APM. Allele loss on short arm of chromosome 17 in breast cancers. Lancet 1988; 2: 1384–5.
15. Hollstein M., Sidransky D., Vogelstein B., Harris CC. p53 Mutations in human cancers. Science 1991; 253: 49–53.
16. Ahuja H., Bar-Eli M., Advani SH, Benchimol S., Clin MJ. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Natl Acad. Sci. USA 1989; 86: 6783–7.
17. Gross RE, Farber S., Martin LW. Neuroblastoma sympatheticum; a study and report of 217 cases. Pediatrics 1959; 23: 1179–91.
18. Weston JJ. The migration and differentiation of neural crest cells. Adv. Morphol. 1970; 8: 41–114.
19. Cavazzana AO, Miser JC, Jefferson J. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am. J. Pathol. 1987; 127: 507–18.
20. Lipinski M., Braham K., Philip I. et al. Neuroectodermal associated antigens on Ewing's sarcoma cell lines. Cancer Res. 1987; 47: 183–7.
21. Thiele CJ, McKeon C., Triche TJ et al. Differential protooncogene expression characterizes histopathologically indistinguishable tumor of the peripheral nervous systems. J. Clin Invest. 1987; 80: 804–11.
22. Vogan K., Bernstein M., Leclerc JM et al. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res. 1993; 53: 5269–73.
23. Komura H., Hayasi Y., Kawamura M. et al. Mutation of p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res. 1993; 53: 5284–8.
24. Gilbert F., Balaban G., Moorhead P., Bianchi D., Schlesinger H. Abnormalities of chromosome 1p in human neuroblastoma tumors cell lines. Cancer Genet. Cyto. 1982; 7: 33–42.
25. Reynolds CP, Biedler JL, Spengler BA et al. Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl Cancer Inst. 1986; 76: 375–87.
26. Rettig WJ, Spengler BA, Chesa PG, Old LJ, Biedler JL. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 1987; 47: 1383–9.
27. Sekiguchi M., Oota T., Sakakibara K., Inui N., Fujn G. Establishment and characterization of a human neuroblastoma cell line in tissue culture. Jpn. Exp. Med. 1979; 49: 67–83.
28. Biedler JL, Spengler BA. A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture. J. Natl Cancer Inst. 1976; 57: 683–95.
29. Goji J., Sano K., Nakamura H., Ito H. Chondrocytic differentiation of peripheral neuroectodermal tumor cell line in nude mouse xenograft. Cancer Res. 1992; 52: 4214–20.
30. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–9.
31. Sano K., Kikuchi A., Matsui Y., Teranishi Y., Takai Y. Tissue-specific expression of a novel GTP-binding protein (smg p25A) mRNA and its increase by nerve growth factor and cyclic AMP in rat pheochromocytoma PC-12 cells. Biochem Biophys. Res. Commun. 1989; 158: 377–85.
32. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets-procedure and some applications. Proc. Natl Acad. Sci. USA 1976; 76: 4350–3.
33. Lamb P., Crawford L. Characterization of human p53 gene Mol. Cell. Biol. 1986; 6: 1379–85.
34. Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR Protocols: A Guide to Methods and Applications. Academic Press, San Diego, CA. 1990; 21–7.
35. Andrew M., Davidoff JC, Nicholas A., Shorter J., Dirk I. Jeffrey R. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene 1992; 7. 127–33.
36. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979; 278: 261–3.
37. Sarnow P., Ho YS, Williams J., Levine AJ. Adenovirus E1b-58K tumor antigen and SV40 large tumor antigen are physically associated with the same 54Kd cellular protein in transformed cells. Cell 1982; 28: 387–94.
38. Oliner JD, Pietenpol JA, Thiagalingam S., Gyuris J., Kinzer KW, Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 1993; 362: 857–60.